77
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Hydrogen sulfide, a potential novel drug, attenuates concanavalin A-induced hepatitis

, , , , , , , , , , , , , , , & show all
Pages 1277-1286 | Published online: 09 Sep 2014
 

Abstract

Background

Hydrogen sulfide (H2S) is known to exert anti-inflammatory properties. Apoptosis and autophagy play important roles in concanavalin A (Con A)-induced acute hepatitis. The purpose of this study was to explore both the effect and mechanism of H2S on Con A-induced acute hepatitis.

Methods

BALB/c mice were randomized into sham group, Con A-injection group, and 14 μmol/kg of sodium hydrosulfide (NaHS, an H2S donor) pretreatment group.

Results

Aspartate aminotransferase, alanine aminotransferase, and pathological damage were significantly ameliorated by NaHS pretreatment. NaHS pretreatment significantly reduced the levels of interleukin-6 and tumor necrosis factor-α compared with those of the Con A group. The expression of Bcl-2, Bax, Beclin-1, and LC3-2, which play important roles in the apoptosis and autophagy pathways, were also clearly affected by NaHS. Furthermore, NaHS affected the p-mTOR and p-AKT.

Conclusion

H2S attenuates Con A-induced acute hepatitis by inhibiting apoptosis and autophagy, in part, through activation of the PtdIns3K-AKT1 signaling pathway.

Acknowledgments

We thank all members of the Central Laboratory of the Tenth Hospital of Tongji University. This project was supported by the National Natural Science Foundation of China (ID: 81270515), the Shanghai Municipal Health Bureau (ID: 2011287, 2012107), and the Liver Diseases Study Fund of China Foundation for Hepatitis Prevention and Control (ID: WBN20100021, CFHPC20131011).

Disclosure

The authors report no conflicts of interest in this work.